Biotech firm CSL Behring has announced the four-year results from the pivotal HOPE-B study confirming the long-term ...

CSL Limited (OTC:CSLLY) and uniQure Inc (NASDAQ:QURE) announced the four-year results from the pivotal HOPE-B study ...

Novo Nordisk’s bispecific antibody Mim8 prevented bleeding events and caused no adverse safety events in the Phase III FRONTIER3 trial. The company plans to file for approval this year, hoping to ...

Global biotechnology leader CSL Behring (ASX:CSL; USOTC: CSLLY (OTC:CSLLY)) announced the four-year results from the HOPE-B ...

Federal funding ensures that hemophilia treatment centers can properly care for those with bleeding disorders, columnist Jennifer Lynne says.

American Healthcare REIT, Inc. (the "Company") announced today that members of its board of directors and management team will ring The Opening Bell® at the New York Stock Exchange on Feb. 10, 2025, ...

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

Yew Chung College of Early Childhood Education (YCCECE) proudly announces the official launch of its Postgraduate Diploma in Education (Early Childhood Education) (PGDE) and Master of Education (MEd) ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

Refacto Market Report 2025 - Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 The Business Research Company's ...

The global prothrombin complex concentrates market is on a strong upward trajectory, with projections indicating substantial growth in the coming decade. According to a recent report by Future Market ...